Site Members can sign up for company wide alerts
Lawsuit Overview
San Diego, Nov. 28, 2011 (Shareholders Foundation) -- An investor in NYSE ABT shares filed a lawsuit against directors of Abbott Laboratories (NYSE: ABT) over alleged breaches of fiduciary duty in connection with alleged off-label marketing of Depakote that cost Abbott Laboratories $1.3billion settlement with the US Government and 24 states. According to the complaint the plaintiff a...
You must register (for free) or login to view the entire case.